Heart failure affects 4% of the US population, yet treatment options are primarily symptomatic, including blood thinners, assistive devices and heart transplant. Patients today face a 50% 5-year survival rate upon diagnosis. It’s time to change that. Our approach is to engineer human cardiac orga...See more
Headquarters:
United States of America
Company Type:
SME
Company size:
1-10 Employees
Address:
SAN FRANCISCO, CA, US
At a glanceLOW
spending power
